| Patent | Date |
|---|
Nlrp3 Modulators
App 20220289736 - Glick; Gary D. ; et al. | 2022-09-15 |
Methods Of Synthesizing Substituted Purine Compounds
App 20210363171 - OLHAVA; Edward James | 2021-11-25 |
Injectable Formulations For Treating Cancer
App 20210353661 - OLHAVA; Edward James ; et al. | 2021-11-18 |
Injectable Formulations For Treating Cancer
App 20210251887 - OLHAVA; Edward James ; et al. | 2021-08-19 |
NLRP3 modulators
Grant 11,072,612 - Glick , et al. July 27, 2 | 2021-07-27 |
Compounds And Compositions For Treating Conditions Associated With Sting Activity
App 20210147467 - Glick; Gary ; et al. | 2021-05-20 |
Methods of synthesizing substituted purine compounds
Grant 10,968,247 - Olhava April 6, 2 | 2021-04-06 |
Compounds and compositions for treating conditions associated with sting activity
Grant 10,961,270 - Glick , et al. March 30, 2 | 2021-03-30 |
Injectable Formulations For Treating Cancer
App 20200397811 - OLHAVA; Edward James ; et al. | 2020-12-24 |
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
Grant 10,723,756 - Glick , et al. | 2020-07-28 |
Compounds And Compositions For Treating Conditions Associated With Sting Activity
App 20200165288 - Glick; Gary ; et al. | 2020-05-28 |
Nlrp3 Modulators
App 20200157096 - Glick; Gary D. ; et al. | 2020-05-21 |
Nlrp3 Modulators
App 20200157097 - Glick; Gary D. ; et al. | 2020-05-21 |
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
Grant 10,604,542 - Glick , et al. | 2020-03-31 |
NLRP3 modulators
Grant 10,556,903 - Glick , et al. Feb | 2020-02-11 |
NLRP3 modulators
Grant 10,533,005 - Glick , et al. Ja | 2020-01-14 |
Injectable Formulations For Treating Cancer
App 20190388335 - OLHAVA; Edward James ; et al. | 2019-12-26 |
Injectable Formulations For Treating Cancer
App 20190350959 - OLHAVA; Edward James ; et al. | 2019-11-21 |
Cyclic Dinucleotide Analogs For Treating Conditions Associated With Sting (stimulator Of Interferon Genes) Activity
App 20190345191 - Glick; Gary D. ; et al. | 2019-11-14 |
Methods Of Synthesizing Substituted Purine Compounds
App 20190300562 - OLHAVA; Edward James | 2019-10-03 |
Substituted 6,5-fused bicyclic heteroaryl compounds
Grant 10,273,223 - Kuntz , et al. | 2019-04-30 |
Nlrp3 Modulators
App 20190055236 - Glick; Gary ; et al. | 2019-02-21 |
Cyclic Dinucleotides For Treating Conditions Associated With Sting Activity Such As Cancer
App 20190031708 - Glick; Gary ; et al. | 2019-01-31 |
Cyclic Dinucleotides For Treating Conditions Associated With Sting Activity Such As Cancer
App 20190016750 - Glick; Gary ; et al. | 2019-01-17 |
Methods Of Synthesizing Substituted Purine Compounds
App 20180134745 - Olhava; Edward James | 2018-05-17 |
Substituted 6,5-fused Bicyclic Heteroaryl Compounds
App 20180072702 - KUNTZ; Kevin Wayne ; et al. | 2018-03-15 |
Salts, Co-crystals, Amorphous Forms, And Crystalline Forms Of A Co-activator-associated Arginine Methyltransferase 1 (carm1) Inhibitor
App 20170298073 - Olhava; Edward James ; et al. | 2017-10-19 |
Injectable Formulations For Treating Cancer
App 20170290765 - Olhava; Edward James ; et al. | 2017-10-12 |
Methods of synthesizing substituted purine compounds
Grant 9,738,679 - Olhava August 22, 2 | 2017-08-22 |
Prmt5 Inhibitors And Uses Thereof
App 20170198006 - Duncan; Kenneth W. ; et al. | 2017-07-13 |
Substituted 6,5-fused bicyclic heteroaryl compounds
Grant 9,637,472 - Kuntz , et al. May 2, 2 | 2017-05-02 |
7-deazapurine Modulators Of Histone Methyltransferase, And Methods Of Use Thereof
App 20160251390 - Chesworth; Richard ; et al. | 2016-09-01 |
Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20160068559 - Chesworth; Richard ; et al. | 2016-03-10 |
Methods Of Synthesizing Substituted Purine Compounds
App 20160024134 - Olhava; Edward James | 2016-01-28 |
Injectable Formulations For Treating Cancer
App 20160022725 - Olhava; Edward James ; et al. | 2016-01-28 |
Substituted 6,5-fused bicyclic heteroaryl compounds
Grant 9,206,157 - Kuntz , et al. December 8, 2 | 2015-12-08 |
Methods of synthesizing substituted purine compounds
Grant 9,175,032 - Olhava November 3, 2 | 2015-11-03 |
Substituted 6,5-Fused Bicyclic Heteroaryl Compounds
App 20150266854 - Kuntz; Kevin Wayne ; et al. | 2015-09-24 |
Substituted 6,5-Fused Bicyclic Heteroaryl Compounds
App 20150065483 - Kuntz; Kevin Wayne ; et al. | 2015-03-05 |
Substituted 6,5-fused bicyclic heteroaryl compounds
Grant 8,962,620 - Kuntz , et al. February 24, 2 | 2015-02-24 |
Methods of Synthesizing Substituted Purine Compounds
App 20150011495 - Olhava; Edward James | 2015-01-08 |
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
Grant 8,722,877 - Chesworth , et al. May 13, 2 | 2014-05-13 |
7-Deazapurine Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20140073597 - Chesworth; Richard ; et al. | 2014-03-13 |
Substituted 6,5-Fused Bicyclic Heteroaryl Compounds
App 20140057891 - Kuntz; Kevin Wayne ; et al. | 2014-02-27 |
Substituted 6,5-fused bicyclic heteroaryl compounds
Grant 8,598,167 - Kuntz , et al. December 3, 2 | 2013-12-03 |
Substituted 6,5-fused Bicyclic Heteroaryl Compounds
App 20130317026 - Kuntz; Kevin Wayne ; et al. | 2013-11-28 |
7-Deazapurine Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20130310334 - Chesworth; Richard ; et al. | 2013-11-21 |
Modulators of Histone Methyltransferase, and Methods of Use Thereof
App 20130310333 - Chesworth; Richard ; et al. | 2013-11-21 |
Substituted purine and 7-deazapurine compounds
Grant 8,580,762 - Olhava , et al. November 12, 2 | 2013-11-12 |
| 